Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells
- 30 January 2012
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 19 (3) , 243-254
Abstract
Prostate cancer remains a leading cause of cancer-related death in men, largely attributable to distant metastases, most frequently to bones. Despite intensive investigations, molecular mechanisms underlying metastasis are not completely understood. Among prostate cancer-derived factors, parathyroid hormone-related peptide (PTHrP), first discovered as an etiologic factor for malignancy-induced hypercalcemia, regulates many cellular functions critical to tumor growth, angiogenesis, and metastasis. In this study, the role of PTHrP in tumor cell survival from detachment-induced apoptosis (i.e. anoikis) was investigated. Reduction ofPTHLH(encoding PTHrP) gene expression in human prostate cancer cells (PC-3) increased the percentage of apoptotic cells when cultured in suspension. Conversely, overexpression of PTHrP protected prostate cancer cells (Ace-1 and LNCaP, both typically expressing low or undetectable basal PTHrP) from anoikis. Overexpression of nuclear localization signal (NLS)-defective PTHrP failed to protect cells from anoikis, suggesting that PTHrP-dependent protection from anoikis is an intracrine event. A PCR-based apoptosis-related gene array showed that detachment increased expression of theTNFgene (encoding the proapoptotic protein tumor necrosis factor-α) fourfold greater in PTHrP-knockdown PC-3 cells than in control PC-3 cells. In parallel,TNFgene expression was significantly reduced in PTHrP-overexpressing LNCaP cells, but not in NLS-defective PTHrP overexpressing LNCaP cells, when compared with control LNCaP cells. Subsequently, in a prostate cancer skeletal metastasis mouse model, PTHrP-knockdown PC-3 cells resulted in significantly fewer metastatic lesions compared to control PC-3 cells, suggesting that PTHrP mediated antianoikis events in the bloodstream. In conclusion, nuclear localization of PTHrP confers prostate cancer cell resistance to anoikis, potentially contributing to prostate cancer metastasis.Keywords
This publication has 33 references indexed in Scilit:
- Roles of Bone Marrow Cells in Skeletal Metastases: No Longer BystandersCancer Microenvironment, 2011
- Cancer to bone: a fatal attractionNature Reviews Cancer, 2011
- The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organsInternational Journal of Cancer, 2011
- Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasisJournal of Bone and Mineral Research, 2010
- Preclinical Mouse Models of Human Prostate Cancer and Their Utility in Drug DiscoveryCurrent Protocols in Pharmacology, 2010
- Dickkopf‐1 (DKK‐1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastasesThe Prostate, 2010
- Targeting anoikis resistance in prostate cancer metastasisMolecular Aspects of Medicine, 2010
- Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survivalRegulatory Peptides, 2009
- PTHrP increases xenograft growth and promotes integrin α6β4 expression and Akt activation in colon cancerCancer Letters, 2007
- Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell linesRegulatory Peptides, 2007